Understanding and developing responses to emerging infectious diseases
Official title: Operations Core
Funded at University of Pittsburgh at Pittsburgh · NIH-10910181 · Data updated 2026-11-12
This study at the University of Pittsburgh is all about finding better ways to understand and fight new infectious diseases, so that patients like you can benefit from improved treatments and prevention methods when facing health threats.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project start | August 18, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $1,006,216 |
| NIH project number | 5UC7AI180311-02 |
| Project ID | NIH-10910181 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals at risk for emerging infectious diseases or those involved in healthcare and public health responses.
✕Less likely to help
Patients with chronic, non-infectious conditions may not receive direct benefits from this research.
What this research studies
This research focuses on the Regional Biocontainment Laboratory at the University of Pittsburgh, which is dedicated to studying emerging infectious diseases and their transmission. The team works on understanding how pathogens evolve and spread, while also developing new medical interventions to prepare for potential pandemics. Patients may benefit from advancements in treatments and preventive measures that arise from this research, as it aims to enhance our ability to respond to biological threats. The research involves collaboration among infection biologists and clinicians who utilize specialized laboratory facilities to conduct their work safely.
Why it matters
Potential benefit: If successful, this research could lead to the development of novel treatments and preventive strategies for infectious diseases that pose a threat to public health.
How similar studies have gone: Previous research in similar biocontainment and infectious disease studies has shown success in developing effective responses to emerging health threats.
Where this research is happening
-
University of Pittsburgh at Pittsburgh
Pittsburgh, United States Active
Researchers
- Principal investigator: Duprex, William Paul — University of Pittsburgh at Pittsburgh
- Study coordinator: Duprex, William Paul
Related research
Other NIH-funded projects on the same topics.
-
Elastomeric membranes for safer pelvic organ prolapse repair
A new 3D-printed elastomeric membrane made from polycarbonate urethane is being tested to replace stiff polypropylene meshes for pelvic organ prolapse in women, aiming to reduce complications.
-
Role of hyaluronan in egg development and ovarian reserve
This grant studies how the hyaluronan matrix in the ovary affects the aging of the female reproductive system and the pool of eggs available.
-
Regulatory switches that control imprinting in early human development
This grant studies how certain genes stay “one-copy” active in early development and what goes wrong in assisted reproduction, with a focus on imprinting disorders.
-
Identifying molecular signs of imprinting errors linked to fertility treatments
This grant studies how assisted reproductive technologies may cause imprinting errors in embryos and how these errors relate to certain birth conditions, with implications for families using infertility treatments.
-
Bioadhesive vaginal film for 7-day protection against HIV, HSV, and pregnancy
A vaginal film that slowly releases antibodies to prevent HIV, HSV, and unintended pregnancy for about a week from a single use.
-
Spermatogonial stem cell transplantation and culture in patients
Researchers are testing a way to transplant or grow sperm-producing cells back in boys and men who stored tissue before cancer treatment, to help them have biological children in the future.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.